NO20035538D0 - Fremgangsmåte for fremstilling av zaleplon - Google Patents

Fremgangsmåte for fremstilling av zaleplon

Info

Publication number: NO20035538D0
Authority: NO; Norway
Prior art keywords: zaleplon; preparation
Prior art date: 2001-06-12

Application number

NO20035538A

Other languages

English (en)

Inventor

Ferenc Korodi

Erika Feher

Erika Magyar

Original Assignee

Biogal Gyogyszergyar

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2001-06-12

Filing date

2003-12-11

Publication date

2003-12-11

2003-12-11 Application filed by Biogal Gyogyszergyar filed Critical Biogal Gyogyszergyar

2003-12-11 Publication of NO20035538D0 publication Critical patent/NO20035538D0/no

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Biomedical Technology (AREA)
Neurology (AREA)
Neurosurgery (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Engineering & Computer Science (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Bioinformatics & Cheminformatics (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Anesthesiology (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

NO20035538A 2001-06-12 2003-12-11 Fremgangsmåte for fremstilling av zaleplon NO20035538D0 (no)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US29763501P	2001-06-12	2001-06-12
PCT/US2002/018567 WO2002100828A2 (en)	2001-06-12	2002-06-12	Process for the production of zaleplon

Publications (1)

Publication Number	Publication Date
NO20035538D0 true NO20035538D0 (no)	2003-12-11

Family

ID=23147125

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO20035538A NO20035538D0 (no)	2001-06-12	2003-12-11	Fremgangsmåte for fremstilling av zaleplon

Country Status (20)

Country	Link
US (2)	US6884888B2 (no)
EP (1)	EP1406871A4 (no)
JP (1)	JP2005507858A (no)
KR (1)	KR20040007683A (no)
CN (1)	CN1537113A (no)
CA (1)	CA2450384A1 (no)
CZ (1)	CZ20033544A3 (no)
DE (1)	DE02778962T1 (no)
ES (1)	ES2223311T1 (no)
HR (1)	HRP20040016A2 (no)
HU (1)	HUP0402257A2 (no)
IL (1)	IL159281A0 (no)
IS (1)	IS7069A (no)
MX (1)	MXPA03011485A (no)
NO (1)	NO20035538D0 (no)
PL (1)	PL372942A1 (no)
SK (1)	SK16232003A3 (no)
TR (1)	TR200402588T3 (no)
WO (1)	WO2002100828A2 (no)
ZA (1)	ZA200309677B (no)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6884888B2 (en) *	2001-06-12	2005-04-26	Teva Gyogyszergyar Reszvenytarsasag	Process for the production of N-[3-(3-cyanopyrazolo[1,5-a] pyrimidin-7-yl) phenyl]-N-ethylacetamide (zaleplon)
US20050032818A1 (en) *	2001-06-12	2005-02-10	Entire Interest	N-[3-(3-cyanopyrazolo[1,5-a]pyrimidin-5-yl)phenyl]-N-ethylacetamide and crystalline forms of zaleplon
HUP0402253A3 (en)	2001-08-01	2005-12-28	Teva Gyogyszergyar Zartkoeruee	Process for the purification of n-[3-(3-cyanopyrazolo[1,5-a]pyrimidin-7-yl)-phenyl]-n-ethylacetamide(zaleplon) and the preparation of its novel crystalline forms and pharmaceutical compositions containing the latters
KR20040086375A (ko) *	2002-02-15	2004-10-08	비오갈 기오기스제르갸르 알티.	소정의 입도 분포를 갖는 잘레플론을 포함하는 분말조성물 및 이로부터 생성된 약학적 생성물
PL207322B1 (pl) *	2002-05-14	2010-11-30	Adamed Społka Z Ograniczoną Odpowiedzialnością	Sposób wytwarzania zaleplonu
WO2004035585A1 (en) *	2002-10-16	2004-04-29	Sanmar Speciality Chemicals Limited	Synthesis of zaleplon
CZ293015B6 (cs) *	2002-10-25	2004-01-14	Léčiva, A.S.	Způsob výroby N-ethyl-N-[3-(3-methyl-pyrazolo[1,5-a]pyrimidin-7-yl)-fenyl]-acetamidu (zaleplonu)
DE112004001615T5 (de) *	2003-09-04	2006-06-14	Cipla Ltd.	Zaleplon-Synthese
AU2004314335A1 (en) *	2004-01-14	2005-08-04	Mallinckrodt Inc.	Two-phase method for the synthesis of selected pyrazolopyrimidines
HUP0400325A3 (en) *	2004-02-02	2005-11-28	Richter Gedeon Vegyeszet	Pure n-[3-(-cyanopyrazolo[1,5-a]pyrimidin-7-yl)phenyl]-n-ethyl-acetamide, process for its preparation and intermediates
WO2005099712A2 (en) *	2004-04-19	2005-10-27	Sanmar Speciality Chemicals Limited	Process for preparation of n-[3-(3-cyanopyrazolo [1,5-a]pyrimidin-7-yl)phenyl]-n-ethylacetamide
WO2006070244A2 (en) *	2004-11-22	2006-07-06	Bakulesh Mafatlal Khamar	A process for the preparation of zaleplon
CN102816163A (zh) *	2012-08-20	2012-12-12	四川禾邦阳光制药股份有限公司	扎来普隆的新晶型及制备方法

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4626538A (en) *	1983-06-23	1986-12-02	American Cyanamid Company	[7-(3-disubstituted amino)phenyl]pyrazolo[1,5-a]pyrimidines
US5714607A (en) *	1995-12-01	1998-02-03	American Cyanamid Company	Process improvement in the synthesis of N- 3-(3-cyano-pyrazolo 1,5-a!pyrimidin-7-yl)phenyl!-N-ethylacetamide
US6485746B1 (en) *	2000-08-25	2002-11-26	Neurocrine Biosciences, Inc.	Controlled-release sedative-hypnotic compositions and methods related thereto
US6384221B1 (en) *	1999-09-02	2002-05-07	Neurocrine Biosciences, Inc.	Polymorphs of N-methyl-N-(3-{3-[2-thienylcarbonyl]-pyrazol-[1,5-α]-pyrimidin-7-yl}phenyl)acetamide and compositions and methods related thereto
IL154088A0 (en) *	2000-08-03	2003-07-31	Wyeth Corp	Polymorphs of zaleplon and methods for the preparation thereof
AR029780A1 (es) *	2000-12-13	2003-07-16	Gador Sa	Procedimiento mejorado para la obtencion de n-[3(3-ciano-pirazolo[1,5-a]pirimidin-7-il)fenil]-n-etil-acetamida
US6884888B2 (en) *	2001-06-12	2005-04-26	Teva Gyogyszergyar Reszvenytarsasag	Process for the production of N-[3-(3-cyanopyrazolo[1,5-a] pyrimidin-7-yl) phenyl]-N-ethylacetamide (zaleplon)
HUP0402253A3 (en) *	2001-08-01	2005-12-28	Teva Gyogyszergyar Zartkoeruee	Process for the purification of n-[3-(3-cyanopyrazolo[1,5-a]pyrimidin-7-yl)-phenyl]-n-ethylacetamide(zaleplon) and the preparation of its novel crystalline forms and pharmaceutical compositions containing the latters
PL207322B1 (pl) *	2002-05-14	2010-11-30	Adamed Społka Z Ograniczoną Odpowiedzialnością	Sposób wytwarzania zaleplonu

2002
- 2002-06-12 US US10/170,673 patent/US6884888B2/en not_active Expired - Fee Related
- 2002-06-12 CN CNA028150112A patent/CN1537113A/zh active Pending
- 2002-06-12 KR KR10-2003-7016185A patent/KR20040007683A/ko not_active Ceased
- 2002-06-12 PL PL02372942A patent/PL372942A1/xx not_active Application Discontinuation
- 2002-06-12 MX MXPA03011485A patent/MXPA03011485A/es not_active Application Discontinuation
- 2002-06-12 CA CA002450384A patent/CA2450384A1/en not_active Abandoned
- 2002-06-12 CZ CZ20033544A patent/CZ20033544A3/cs unknown
- 2002-06-12 IL IL15928102A patent/IL159281A0/xx unknown
- 2002-06-12 JP JP2003503597A patent/JP2005507858A/ja active Pending
- 2002-06-12 HU HU0402257A patent/HUP0402257A2/hu unknown
- 2002-06-12 DE DE02778962T patent/DE02778962T1/de active Pending
- 2002-06-12 HR HR20040016A patent/HRP20040016A2/hr not_active Application Discontinuation
- 2002-06-12 ES ES02778962T patent/ES2223311T1/es active Pending
- 2002-06-12 EP EP02778962A patent/EP1406871A4/en not_active Withdrawn
- 2002-06-12 WO PCT/US2002/018567 patent/WO2002100828A2/en not_active Application Discontinuation
- 2002-06-12 SK SK1623-2003A patent/SK16232003A3/sk unknown
- 2002-06-12 TR TR2004/02588T patent/TR200402588T3/xx unknown
2003
- 2003-12-10 IS IS7069A patent/IS7069A/is unknown
- 2003-12-11 NO NO20035538A patent/NO20035538D0/no not_active Application Discontinuation
- 2003-12-12 ZA ZA200309677A patent/ZA200309677B/en unknown
2005
- 2005-02-25 US US11/067,044 patent/US20050187225A1/en not_active Abandoned

Also Published As

Publication number	Publication date
EP1406871A4 (en)	2005-01-26
WO2002100828A2 (en)	2002-12-19
US6884888B2 (en)	2005-04-26
US20030040522A1 (en)	2003-02-27
ZA200309677B (en)	2004-12-13
WO2002100828A3 (en)	2003-05-01
CZ20033544A3 (cs)	2004-11-10
ES2223311T1 (es)	2005-03-01
EP1406871A2 (en)	2004-04-14
HRP20040016A2 (en)	2004-10-31
DE02778962T1 (de)	2005-02-10
CN1537113A (zh)	2004-10-13
IS7069A (is)	2003-12-10
TR200402588T3 (tr)	2004-11-22
IL159281A0 (en)	2004-06-01
MXPA03011485A (es)	2004-06-11
HUP0402257A2 (hu)	2005-02-28
CA2450384A1 (en)	2002-12-19
PL372942A1 (en)	2005-08-08
KR20040007683A (ko)	2004-01-24
JP2005507858A (ja)	2005-03-24
SK16232003A3 (sk)	2004-12-01
US20050187225A1 (en)	2005-08-25

Publication	Publication Date	Title
NO20042680L (no)	2004-06-25	Fremgangsmater for fremstilling av O-demetylvenflaxine
NO20030012L (no)	2003-03-03	Fremgangsmåte for fremstilling av substituerte oktanoylamider
NO20013942L (no)	2002-02-19	Fremgangsmate for fremstilling av Citalopram
NO20040027L (no)	2004-01-05	Fremgangsmate for fremstillingen av escitalopram
NO20040278L (no)	2004-01-21	Fremgangsmate for fremstilling av perindopril
NO20030163L (no)	2003-02-27	Fremgangsmate for fremstilling av olefiner
FI20011541A0 (fi)	2001-07-13	Menetelmä massan valmistamiseksi
NO20032731D0 (no)	2003-06-16	Fremgangsmåte for fremstilling av sulfonamid-substituerte imidazotriazinoner
NO20041200L (no)	2004-03-23	Fremgangsmate for fremstilling av citalopram.
NO20035538D0 (no)	2003-12-11	Fremgangsmåte for fremstilling av zaleplon
NO20044814L (no)	2004-01-07	Fremgangsmate for fremstilling av combretastaniner
NO20034003L (no)	2003-10-22	Fremgangsmåte for fremstilling av imidazolforbindelser
NO20023445D0 (no)	2002-07-18	Fremgangsmåte for fremstilling av peptider
NO20042640L (no)	2004-06-23	Fremgangsmate for fremstilling av ekinocandinderivater
NO20025423L (no)	2002-11-12	Fremgangsmate for fremstilling av Citalopram
NO20026155L (no)	2003-02-19	Fremgangsmåte for fremstilling av lavere olefiner
NO20035586L (no)	2003-12-15	Fremgangsmate for fremstilling av cykloheksanol-derivater
NO20035136D0 (no)	2003-11-18	Fremgangsmåte til fremstilling av imipenem
NO20030515L (no)	2003-03-31	Fremgangsmåte for fremstilling av dinapsolin
NO20021118D0 (no)	2002-03-06	Fremgangsmåte for fremstilling av citalopram
FI20010472A0 (fi)	2001-03-09	Menetelmä alfa-pineenin hydraamiseksi
NO20023702D0 (no)	2002-08-06	Fremgangsmåte for fremstilling av 5-arylnikotinaldehyder
NO20035138D0 (no)	2003-11-18	Fremgangsmåte til fremstilling av amorft natriumsilastatin
FI20010892A0 (fi)	2001-04-27	Menetelmä ksylitolin valmistamiseksi
NO20041193L (no)	2004-03-22	Fremgangsmåte til fremstilling av beta-ionylidenacetaldehyd

Legal Events

Date	Code	Title	Description
2007-01-22	FC2A	Withdrawal, rejection or dismissal of laid open patent application